Human Papillomavirus Vaccination in the United States: Uneven Uptake by Gender, Race/Ethnicity, and Sexual Orientation
Human Papillomavirus Vaccination in the United States: Uneven Uptake by Gender, Race/Ethnicity, and Sexual Orientation
复制标题
DOI：
10.2105/ajph.2015.303039
复制
发表时间：
2016-04-01
影响因子：
12.7
通讯作者：
Parker, Edith A.
中科院分区：
文献类型：
--
作者：
Daniel-Ulloa, Jason;Gilbert, Paul A.;Parker, Edith A.
目标.通过性别、种族/民族和性取向评估美国年轻人人乳头瘤病毒（HPV）疫苗接种的国家差异。我们测试了HPV疫苗系列开始和完成的组间差异（即，通过Rao-Scott chi（2）测试，在2013年全国健康访谈调查的6444名18至30岁的受访者中进行了3次剂量）。在男性中，5%的人报告接受了HPV疫苗，种族/种族或性取向的摄取没有差异。相比之下，30%的女性报告接受了HPV疫苗，与白色女性相比，有色人种女性开始和完成疫苗接种的几率较低。在美国，HPV疫苗接种率在男性中落后，在女性中存在差异。增加有色人种女性和所有男性的HPV疫苗接种率和系列完成率可能会带来相当大的长期公共卫生益处。
Objectives. To assess national differences in human papillomavirus (HPV) vaccine uptake among young adults in the United States by gender, race/ethnicity, and sexual orientation.Methods. We tested group differences in initiation and completion of the HPV vaccine series (i.e., 3 doses) by Rao-Scott chi(2) test among 6444 respondents aged 18 to 30 years from the 2013 National Health Interview Survey.Results. Among men, 5% reported receiving the HPV vaccine, with no differences in uptake by race/ethnicity or sexual orientation. By contrast, 30% of the women reported receiving the HPV vaccine, with women of color having lower odds of initiating and completing the vaccine series compared with White women.Conclusions. In the United States, HPV vaccine rates are lagging in men and show disparities among women. Increasing HPV vaccine uptake and series completion among women of color and all men may provide considerable long-term public health benefits.